Position in FBIO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$112,855
-$46,648 QoQ
Shares Held
40,450
-6.2% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $658,704,928 across 179 Biotechnology names. FBIO ranks #139 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,900,824 | $178,905,554 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
151,191 | $116,816,214 | |
| 3 | LEGN |
Legend Biotech Corp
|
1,527,336 | $27,629,508 | |
| 4 | TBPH |
Theravance Biopharma, Inc.
|
1,276,576 | $20,718,828 | |
| 5 | RIGL |
Rigel Pharmaceuticals Inc
|
666,426 | $18,020,159 | |
| 6 | IMCR |
Immunocore Holdings plc
|
501,091 | $15,107,893 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
1,547,593 | $15,042,603 | |
| 8 | PBYI |
Puma Biotechnology, Inc.
|
2,041,759 | $13,046,840 |
All Filings in FBIO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $112,855 | 40,450 | Shares | Defined | 2026-05-13 | |
| 2025-09-30 | $159,503 | 43,109 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $34,514 | 18,556 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $141,189 | 90,506 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $376,518 | 185,477 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $699,762 | 482,595 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $474,538 | 277,508 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $584,116 | 292,058 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $391,865 | 130,188 | Shares | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||